{"result_id": "086005", "URL": "https://www.cureus.com/articles/102889", "timestamp": "2023-04-25 14:52:58 CEST+0200", "meta": {"description": "Immune thrombocytopenic purpura (ITP) has been linked to the COVID-19 vaccine series as a rare adverse event but has recently emerged in the literature as a sequela of natural COVID-19 infection. ITP is a diagnosis of exclusion where a diagnosis is made by having isolated thrombocytopenia (platelet count &lt;100,000/\u03bcL) and no other identifiable etiology for the thrombocytopenia. We share the case of a young male without any history of hematological or immunological disorders presenting with severe, symptomatic thrombocytopenia following a natural COVID-19 infection. Patients\u00a0should be made aware of the potential risk of adverse events with not only vaccination but also even mild cases of natural infection with COVID-19. An emphasis should be placed on the fact that the benefits of vaccination continue to outweigh the potential risks of adverse events, even in those with a pre-existing diagnosis of ITP.", "lang": "en", "keywords": "", "favicon": "https://assets.cureus.com/packs/media/images/favicon-6b3259c58f4356da2cc885357cfda20b.png", "canonical": "https://www.cureus.com/articles/102889", "encoding": "utf-8"}, "image": null, "domain": "www.cureus.com", "title": "Immune Thrombocytopenic Purpura (ITP) Following Natural COVID-19 Infection", "cleaned_text": "On May 25, 2018, the GDPR (General Data Protection Regulation) went into effect and changed how organizations deal with personal data of customers located in the EU. Though GDPR was built to protect Europeans, it will affect organizations around the world doing business in the EU. Because of this we are asking our users located in the EU to opt in to the data we collect in order to bring a better web experience. Opt-In", "opengraph": {"title": "Immune Thrombocytopenic Purpura (ITP) Following Natural COVID-19 Infection", "type": "article", "image": "https://public.cureus.com/fallback/new_default_article_image_1.png", "description": "Immune thrombocytopenic purpura (ITP) has been linked to the COVID-19 vaccine series as a rare adverse event but has recently emerged in the literature as a sequela of natural COVID-19 infection. ITP is a diagnosis of exclusion where a diagnosis is made by having isolated thrombocytopenia (platelet count &lt;100,000/\u03bcL) and no other identifiable etiology for the thrombocytopenia. We share the case of a young male without any history of hematological or immunological disorders presenting with severe, symptomatic thrombocytopenia following a natural COVID-19 infection. Patients\u00a0should be made aware of the potential risk of adverse events with not only vaccination but also even mild cases of natural infection with COVID-19. An emphasis should be placed on the fact that the benefits of vaccination continue to outweigh the potential risks of adverse events, even in those with a pre-existing diagnosis of ITP."}, "tags": [], "tweets": [], "movies": [], "links": ["/users/gdpr_opt_in"], "authors": ["Atefeh Kalantary", "Bilal Malik", "Arvind Kunadi", "Sisira Santhosh"], "publish_date": null}